Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose?

Elad Moisseiev; Anat Loewenstein

doi:10.1038/s41433-019-0706-6

Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose?

Elad Moisseiev^*, Anat Loewenstein

^*Corresponding author for this work

Ophthalmology

Research output: Contribution to journal › Editorial

3 Scopus citations

Original language	English
Pages (from-to)	219-220
Number of pages	2
Journal	Eye (Basingstoke)
Volume	34
Issue number	2
DOIs	https://doi.org/10.1038/s41433-019-0706-6
State	Published - 1 Feb 2020

Access to Document

10.1038/s41433-019-0706-6

Cite this

@article{e7cf58ff80f64d19a90757a8d71f1aeb,

title = "Initial treatment of macular oedema due to central retinal vein occlusion—which anti-VEGF agent to choose?",

author = "Elad Moisseiev and Anat Loewenstein",

year = "2020",

month = feb,

day = "1",

doi = "10.1038/s41433-019-0706-6",

language = "אנגלית",

volume = "34",

pages = "219--220",

journal = "Eye (Basingstoke)",

issn = "0950-222X",